Cymbiotika
“Can a premium DTC supplement brand sustain its growth trajectory while successfully crossing over into retail and international markets?”
Founded2018
HQSan Diego, CA 92121
Total raised$55M+
Latest roundSeed, 2024
IndustryE-commerce / DTC brand
The story
Founded in 2018 as a DTC supplement brand built around premium liposomal formulations, Cymbiotika grew to $150M in revenue entirely through direct e-commerce before pivoting toward omnichannel retail and international expansion in 2024. The $30M RevTek debt round was specifically structured to fund wholesale/retail channel entry and the Canadian market launch — a meaningful shift from pure DTC. The adoption of NetSuite ERP signals a professionalisation of back-office infrastructure to support this channel diversification.
Last 12 months
Product timeline
2018
Cymbiotika founded in San Diego as a DTC wellness and nutritional supplements brand focused on liposomal delivery technology.· pivot
2024
Reached $150M in annual revenue and raised $25M seed round from celebrity investors.· banking
2024
Secured $30M debt financing from RevTek Capital to fund retail expansion, Canadian market entry, and infrastructure automation.· lending
2024
Migrated financial operations to NetSuite ERP, reducing month-end close from 30+ days to 10 days.· acquisition
The stack
3 layers disclosed in Cymbiotika’s embedded-finance stack
Payments / PSP
Shopify Payments (self-operated)
Lending
in the full report
Accounting
in the full report
Accounting gap: minor
3 more providers across 2 layers, with confidence-scored evidence and source URLs, are in the Embedded Finance Index report.